Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Winlevi for acne

Aug. 27, 2020

Conditional E.U. approval for Idefirix for highly sensitized kidney transplant patients

Aug. 27, 2020

Novartis details development of best-in-class LTA4 hydrolase inhibitor LYS-006

Aug. 27, 2020

Debiopharm begins phase I study of Debio-1124 for small cell carcinoma

Aug. 27, 2020

MK-4710: a new potent, selective, brain-penetrant M4R PAM suitable for clinical development

Aug. 27, 2020

Oncology Venture to advance stenoparib into clinical trials for COVID-19

Aug. 27, 2020

New IL-17A/IL-17RA interaction inhibitors patented by DiCE Molecules

Aug. 27, 2020

Capulus Therapeutics synthesizes new SREBP inhibitors

Aug. 27, 2020

Lilly discovers KCNQ2/3 channel activators

Aug. 27, 2020

DNA polymerase theta inhibitors identified at Ideaya Biosciences

Aug. 27, 2020

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...